Susan Thompson

About Susan Thompson

A change agent with nearly 20 years’ experience in VP, Senior Director, and Director Patient Access and Market Access roles driving strategies in the areas of health policy, reimbursement, government affairs, advocacy, and awareness. Strong business acumen a seasoned and collaborative leader skilled in role modeling, mentoring, and motivating staff and stakeholders to achieve aggressive goals and objectives. Industry experience spans the fields of biotechnology, pharmaceuticals, medical devices, capital equipment, oncology, radiation oncology, surgery, biologics, autoimmune disorders, chronic pain, and spasticity. Management experience includes a remote international team of five market access professionals with global responsibility for a radiation oncology equipment manufacturer. In this role engaged with global stakeholders including the World Health Organization (WHO), the National Health System (NHS), Ministries of Health in Asia, leading European specialty societies and cancer research organizations, and government officials and public and private payers in the United States. By implementing creative solutions to complex problems, have facilitated sales at critical times in product lifecycles increasing system sales revenue by over $200M and annual recurring service revenue by over $100M. In the process have shaped private and public payer policies across the globe, including U.S. Medicare policy through the development of a CMS certified Quality Clinical Data Registry (QCDR) for prostate cancer. Career began developing market access strategies to support adoption of novel therapeutics including an intrathecal analgesic made from the venom of a marine snail, a monoclonal antibody for autoimmune disorders, and a botulinum toxin to treat a variety of disorders.Recently market access experience includes overhauling the regulatory strategy for a surgical oncology start-up to maximize reimbursement on market entry. Remote based. Open to travel.

Experience

1. Vice President, Patient Access

   Reflexion Medical

   May 2025 — Present